Literature DB >> 17193031

Ordered mesoporous silica SBA-15: a new effective adjuvant to induce antibody response.

Lucildes P Mercuri1, Luciana V Carvalho, Flávia A Lima, Carolina Quayle, Márcia C A Fantini, Gabriela S Tanaka, Wafa H Cabrera, Maria F D Furtado, Denise V Tambourgi, Jivaldo do R Matos, Mietek Jaroniec, Osvaldo A Sant'Anna.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17193031     DOI： 10.1002/smll.200500274

Source DB:  PubMed          Journal:  Small        ISSN： 1613-6810            Impact factor:   13.281


× No keyword cloud information.
  25 in total

1.  Engineering an effective immune adjuvant by designed control of shape and crystallinity of aluminum oxyhydroxide nanoparticles.

Authors:  Bingbing Sun; Zhaoxia Ji; Yu-Pei Liao; Meiying Wang; Xiang Wang; Juyao Dong; Chong Hyun Chang; Ruibin Li; Haiyuan Zhang; André E Nel; Tian Xia
Journal:  ACS Nano       Date:  2013-12-02       Impact factor: 15.881

Review 2.  Prophylactic vaccine delivery systems against epidemic infectious diseases.

Authors:  Chao Pan; Hua Yue; Li Zhu; Guang-Hui Ma; Heng-Liang Wang
Journal:  Adv Drug Deliv Rev       Date:  2021-07-17       Impact factor: 17.873

3.  Silica nanoparticles as the adjuvant for the immunisation of mice using hepatitis B core virus-like particles.

Authors:  Dace Skrastina; Ivars Petrovskis; Ilva Lieknina; Janis Bogans; Regina Renhofa; Velta Ose; Andris Dishlers; Yuri Dekhtyar; Paul Pumpens
Journal:  PLoS One       Date:  2014-12-01       Impact factor: 3.240

Review 4.  Silica micro/nanospheres for theranostics: from bimodal MRI and fluorescent imaging probes to cancer therapy.

Authors:  Shanka Walia; Amitabha Acharya
Journal:  Beilstein J Nanotechnol       Date:  2015-02-24       Impact factor: 3.649

Review 5.  Nanomaterials in the Context of Type 2 Immune Responses-Fears and Potentials.

Authors:  Martin Himly; Robert Mills-Goodlet; Mark Geppert; Albert Duschl
Journal:  Front Immunol       Date:  2017-04-25       Impact factor: 7.561

6.  Assessment of the adjuvant activity of mesoporous silica nanoparticles in recombinant Mycoplasma hyopneumoniae antigen vaccines.

Authors:  Veridiana Gomes Virginio; Natalia Costantin Bandeira; Fernanda Munhoz Dos Anjos Leal; Marcelo Lancellotti; Arnaldo Zaha; Henrique Bunselmeyer Ferreira
Journal:  Heliyon       Date:  2017-01-06

7.  A universal polysaccharide conjugated vaccine against O111 E. coli.

Authors:  Gabrielle R Andrade; Roger R C New; Osvaldo A Sant'Anna; Neil A Williams; Rosely C B Alves; Daniel C Pimenta; Hugo Vigerelli; Bruna S Melo; Letícia B Rocha; Roxane M F Piazza; Lucia Mendonça-Previato; Marta O Domingos
Journal:  Hum Vaccin Immunother       Date:  2014-11-21       Impact factor: 3.452

8.  Immunisation of Sheep with Bovine Viral Diarrhoea Virus, E2 Protein Using a Freeze-Dried Hollow Silica Mesoporous Nanoparticle Formulation.

Authors:  Donna Mahony; Karishma T Mody; Antonino S Cavallaro; Qiuhong Hu; Timothy J Mahony; Shizhang Qiao; Neena Mitter
Journal:  PLoS One       Date:  2015-11-04       Impact factor: 3.240

9.  Oxidative Damage and Energy Metabolism Disorder Contribute to the Hemolytic Effect of Amorphous Silica Nanoparticles.

Authors:  Lizhen Jiang; Yongbo Yu; Yang Li; Yang Yu; Junchao Duan; Yang Zou; Qiuling Li; Zhiwei Sun
Journal:  Nanoscale Res Lett       Date:  2016-02-02       Impact factor: 4.703

Review 10.  Nanoparticle Vaccines Adopting Virus-like Features for Enhanced Immune Potentiation.

Authors:  Saborni Chattopadhyay; Jui-Yi Chen; Hui-Wen Chen; Che-Ming Jack Hu
Journal:  Nanotheranostics       Date:  2017-06-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.